Attention Deficit/Hyperactivity Disorder

References

Adriani W, Rea M, et al. Acetyl-L-carnitine reduces impulsive behaviour in adolescent rats. Psychopharmacology (Berl). 2004 Nov;176(3-4):296-304.

Akhondzadeh S, Mohammadi MR, et al. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]. BMC Psychiatry. 2004 Apr 8;4:9.

Arnold LE, Bozzolo H, et al. Serum zinc correlates with parent- and teacher- rated inattention in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005a Aug;15(4):628-36.

Arnold LE, DiSilvestro RA. Zinc in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005b Aug;15(4):619-27.

Bandstra ES, Morrow CE, et al. Longitudinal investigation of task persistence and sustained attention in children with prenatal cocaine exposure. Neurotoxicol Teratol. 2001 Nov;23(6):545-59.

Barkley R. ADHD and the Nature of Self Control. New York, NY: Guilford; 1997: 136-42.

Betancourt-Fursow de Jiminez YM, Jiminez-Leon JC, et al. Attention deficit hyperactivity disorder and sleep disorders [in Spanish]. Rev Neurol. 2006 Feb 13;42(suppl 2):S37-S51.

Biederman J, Mick E, et al. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000 May;157(5):816-8.

Bilici M, Yildirim F, et al. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):181-90.

Boris M, Mandel FS. Foods and additives are common causes of the attention deficit hyperactive disorder in children. Ann Allergy. 1994 May;72(5):462-8.

Chaves-Carballo E. Diet therapy in the treatment of neuropediatric disorders [in Spanish]. Rev Neurol. 2003 Aug 1-15;37(3):267-74.

Christman AK, Fermo JD, et al. Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder. Pharmacotherapy. 2004 Aug;24(8):1020-36.

Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res. 2000;126:325-41.

Davenport TH, Beck JC. Getting the attention you need. Harv Bus Rev. 2000 Sep;78(5):118-26, 200.

Daviss WB, Bentivoglio P, et al. Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression. J Am Acad Child Adolesc Psychiatry. 2001 Mar;40(3):307-14.

Egger J, Carter CM, et al. Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome. Lancet. 1985 Mar 9;1(8428):540-5.

Girardi NL, Shaywitz SE, et al. Blunted catecholamine responses after glucose ingestion in children with attention deficit disorder. Pediatr Res. 1995 Oct;38(4):539-42.

Goddard J. Perceived passage of time: its possible relationship to attention-deficit hyperactivity disorder. Med Hypotheses. 2000 Oct;55(4):351-2.

Haag M. Essential fatty acids and the brain. Can J Psychiatry. 2003 Apr;48(3):195-203.

Hamrin V, Bailey K. Gabapentin and methylphenidate treatment of a preadolescent with attention deficit hyperactivity disorder and bipolar disorder. J Child Adolesc Psychopharmacol. 2001;11(3):301-9.

Harding KL, Judah RD, et al. Outcome-based comparison of Ritalin versus food-supplement treated children with AD/HD. Altern Med Rev. 2003 Aug;8(3):319-30.

Hartman CA, Willcutt EG, et al. The relation between sluggish cognitive tempo and DSM-IV ADHD. J Abnorm Child Psychol. 2004 Oct;32(5):491-503.

Holtkamp K, Peters-Wallraf B, et al. Methylphenidate-related growth impairment. J Child Adolesc Psychopharmacol. 2002 Spring;12(1):55-61.

Joshi K, Lad S, et al. Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD). Prostaglandins Leukot Essent Fatty Acids. 2006 Jan;74(1):17-21.

Kasper DL, Braunwald E, et al, eds. Harrison’s Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005.

Kelsey DK, Sumner CR, et al. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics. 2004 Jul;114(1):e1-e8.

Kidd PM. Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management. Altern Med Rev. 2000 Oct;5(5):402-28.

Konofal E, Lecendreux M, et al. Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2004 Dec;158(12):1113-5.

Krummel DA, Seligson FH, et al. Hyperactivity: is candy causal? Crit Rev Food Sci Nutr. 1996 Jan;36(1-2):31-47.

Levin ED, Conners CK, et al. Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol. 2001 Feb;9(1):83-90.

Lyon MR, Cline JC, et al. Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study. J Psychiatry Neurosci. 2001 May;26(3):221-8.

Maayan R, Yoran-Hegesh R, et al. Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder. Neuropsychobiology. 2003;48(3):111-5.

Mercugliano M. What is attention-deficit/hyperactivity disorder? Pediatr Clin North Am. 1999 Oct;46(5):831-43.

Millichap JG, Yee MM, et al. Serum ferritin in children with attention-deficit hyperactivity disorder. Pediatr Neurol. 2006 Mar;34(3):200-3.

Mitsis EM, Halperin JM, et al. Serotonin and aggression in children. Curr Psychiatry Rep. 2000 Apr;2(2):95-101.

Mousain-Bosc M, Roche M, et al. Magnesium VitB6 intake reduces central nervous system hyperexcitability in children. J Am Coll Nutr. 2004 Oct;23(5):545S-548S.

National Institutes of Health 2006. Available at: http://www.nimh.nih.gov/healthinformation/adhdmenu.cfm. Accessed June 15, 2006.

Nogovitsina OR, Levitina EV. Diagnostic value of examination of the magnesium homeostasis in children with attention deficit syndrome with hyperactivity [in Russian]. Klin Lab Diagn. 2005 May;(5):17-9.

Nogovitsina OR, Levitina EV. Effect of MAGNE-B6 on the clinical and biochemical manifestations of the syndrome of attention deficit and hyperactivity in children [in Russian]. Eksp Klin Farmakol. 2006a Jan-Feb;69(1):74-7.

Nogovitsina OR, Levitina EV. Neurological aspect of clinical symptoms, pathophysiology and correction in attention deficit hyperactivity disorder [in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2006b;106(2):17-20.

Overmeyer S, Bullmore ET, et al. Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network. Psychol Med. 2001 Nov;31(8):1425-35.

Paule MG, Rowland AS, et al. Attention deficit/hyperactivity disorder: characteristics, interventions and models. Neurotoxicol Teratol. 2000 Sep;22(5):631-51.

Pliszka SR. Neuroimaging and ADHD. ADHD Report. 2002;10:1016.

Ponce AG, Rodriguez-Jimenez CR, et al. Attention-deficit hyperactivity disorder and vulnerability to the development of alcoholism: use of the Wender-Utah Rating Scale for retrospective diagnosis of ADHD in the childhood of alcoholic patients [in Spanish]. Actas Esp Psiquiatr. 2000 Nov;28(6):357-66.

Rice DC. Parallels between attention deficit hyperactivity disorder and behavioral deficits produced by neurotoxic exposure in monkeys. Environ Health Perspect. 2000 Jun;108(suppl 3):405-8.

Rowe KS, Rowe KJ. Synthetic food coloring and behavior: a dose response effect in a double-blind, placebo-controlled, repeated-measures study. J Pediatr. 1994 Nov;125(pt 1):691-8.

Schnoll R, Burshteyn D, et al. Nutrition in the treatment of attention-deficit hyperactivity disorder: a neglected but important aspect. Appl Psychophysiol Biofeedback. 2003 Mar;28(1):63-75.

Stevens L, Zhang W, et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids. 2003 Oct;38(10):1007-21.

Strous RD, Spivak B, et al. Analysis of neurosteroid levels in attention deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2001 Sep;4(3):259-64.

Sunohara GA, Roberts W, et al. Linkage of the dopamine D4 receptor gene and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2000 Dec;39(12):1537-42.

Tantillo M, Kesick CM, et al. The effects of exercise on children with attention-deficit hyperactivity disorder. Med Sci Sports Exerc. 2002 Feb;34(2):203-12.

Taylor FB, Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol. 2000;10(4):311-20.

Warner-Rogers J, Taylor A, et al. Inattentive behavior in childhood: epidemiology and implications for development. J Learn Disabil. 2000 Nov;33(6):520-36.

Weiler MD, Bernstein JH, et al. Processing speed in children with attention deficit/hyperactivity disorder, inattentive type. Neuropsychol Dev Cogn C Child Neuropsychol. 2000 Sep;6(3):218-34.

Weiss MD, Wasdell MB, et al. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatry. 2006 May;45(5):512-9.

White BP, Becker-Blease KA, et al. Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample. J Am Coll Health. 2006 Mar-Apr;54(5):261-8.

Wilens TE, Waxmonasky J, et al. An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005 Dec;15(6):947-55.

Young GS, Conquer JA, et al. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder. Reprod Nutr Dev. 2005 Sep-Oct;45(5):549-58.